Infotronicx ANDA (Abbreviated New Drug Application) tracking solution allows you to manage the complete life cycle of applications filed against regulatory, starting from controlled correspondence to updating regulatory on the changes and events. ANDA submissions can be managed until the closure with early alarms on commitment dates.
Our Abbreviated New Drug Application (ANDA) tracker helps Regulatory Department or Quality Control (QC) Department of the Pharma and Biotech companies in tracking the applications and meeting the regulatory commitment dates with early Alarms.
After receiving the receipt of approval from the US FDA, the Pharmaceutical and Biotech companies need to communicate for the product changes, provide a response to deficiencies and other queries to regulatory against the assigned ANDA Application Number.
Mentioning the above information, organizations need to submit the Periodic Adverse Drug Experience Report (PADER) along with eCTD details on quarterly or annually basis.
Along with the communications to Regulatory, the Pharma or Biotech industries also need to communicate the same to customers.
The DMF, Drug master files follow a similar kind of process.
Keeping track of Goal dates and the commitments given to regulatory is
quite challenging and sometimes the organizations miss their due dates
results in delays and deviations.
Features of Infotronicx ANDA Tracking Solution
Product Master to manage all the products
Separate sub trackers for entering Controlled Correspondence, Supplements, CR, Deficiency, Pader, Notifications.
Controlled Correspondence Tracking with RLD (Reference Listed Drug) Name, RLD Number, CC Filled and Sent by, Title of inquiry along with FDA Assigned Number, Responded dates along with FDA comments.
Infotronicx ANDA and DMF Tracker can allow to record and track customer notifications Like Initial Notification Date, Customer Inquiries, Amendments Submission date and Final Notification.
Customer Queries along with Query receipt date, Target date, and Completion date.
Deficiency Tracker includes the Deficiency Type, Deficiency Description, Action Items, Responsibility and Deficiency Response/Closure Dates along with the root cause.
Supplement Types, Supplement against Deficiency, Supplement Grant Date, Request Date, FDA Response and the Date of Response along with RA comments.
The detailed description of Change Controls against the products that include Existing and proposed change, Reason/Justification, Change Classification RA & QA, Link with customer notifications along with Implementation Timelines, Completion of change and effectiveness details.
PADER Tracker allows Periodic Adverse Drug Experience Report submission details along with time period, eCTD date and Submission Date.
Abbreviated New Drug Application (ANDA) Tracker allows extracting the data from other systems namely change controls and Market Complaints about Adverse events.
Restricted access to users based on their Job responsibility. Regulatory users can access all the sheets but the QA can access specific sheets.
Benefits of Infotronicx ANDA Tracker
Single mouse click on the ANDA application number will give the complete details of information, the communications, and the latest status.
Infotronicx System will auto alerts on the Target dates and Due Dates, ensures timely responses to Regulatory and Customer Queries.
Dashboards give the Complete Picture of the ANDA Filings.
Deficiencies, supplement details from other products help in filing reparation for similar kind of products.